Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Impacts of Superselective Infarct-related Artery (IRA) Infusion of Tirofiban on Myocardial Reperfusion and Bleeding Complications in Acute Myocardial Infarction (AMI) Patients (SUIT-AMI)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2010 by Beijing Anzhen Hospital.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
Beijing Anzhen Hospital
ClinicalTrials.gov Identifier:
NCT01181388
First received: August 11, 2010
Last updated: August 12, 2010
Last verified: June 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2012
  Estimated Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)